Top Marijuana Shares in the NASDAQ
Even though the majority of U.S.-based cannabis businesses and lots of foreign American Depository Receipts (ADRs) trade on the countertop (OTC), a few cannabis organizations are traded regarding the NASDAQ. Some investors choose stocks being noted on the NASDAQ with other exchanges because of their increased liquidity and tighter spreads when compared to markets that are over-the-counter. For instance, whilst the cannabis industry is continuing to grow in current months and years, uplisting from an OTC market to a professional U.S. trade has grown to become an advertising achievement for all increasing marijuana organizations. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)
An increasing amount of cannabis organizations are now being noted on reputable U.S. exchanges in place of being exchanged in the OTC market showing the quick development of the cannabis industry.
NASDAQ-listed Marijuana shares
The NASDAQ had been the initial exchange that is electronic is certainly synonymous with technology and biotechnology. The cannabis businesses from the NASDAQ mirror this, in addition to almost all them run into the area that is biotech of industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, at the time of October 26, 2019, with a failure of the total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is just a biotech business mixed up in production of medical cannabis medications. Research and development around Arena’s APD371 may be the focus that is primary of company’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is a check this is certainly blank that is in a merger contract with Kalyx developing Inc. Kalyx is a prominent investment rely upon the regulated cannabis industry in america.
- The cannabis industry, particularly the part of cannabis and biotech, is attracting significant investor attention.
- Cannabis has been utilized in brand brand new drugs for the treating discomfort and chronic that is many inflammatory, and fibrotic conditions.
- Organizations will also be developing cannabinoid services and products for autism range disorders, schizophrenia, glioma, Tourette problem, epileptic disorders, Prader-Willi Syndrome (a hereditary disorder), and amphetamine addiction.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is just a clinical-stage biotechnology business focused on developing and commercializing chemical that is new for the indications of discomfort and pruritus (itching). Although most of the firm’s clinical-stage products target opioid receptors, Cara happens to be performing preclinical research on cannabinoids for the treating neuropathic discomfort.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The team’s research, development, and production are based around cannabis medications that look for to take care of chronic, inflammatory, fibrotic, along with other conditions.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is a cannabis that are canadian. The team has and seeks cannabis-related subsidiaries and licensed producers. In December of 2018, Marlboro maker Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not only with additional money to invest in its continued expansion but additionally with a well-established partner skilled into the advertising of customer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis company. It distributes a number of cannabis usage accessories and vaporization gear and items to customers that are retail the U.S. and Canada. Furthermore, it runs e-commerce sites for extra product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is creating a profile of cannabinoid medications. These medications consist of Sativex for the treating spasticity associated with sclerosis that is multiple cancer tumors discomfort and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more than a dozen nations away from united states of america and contains gotten regulatory approval in various other nations. Epidiolex received Food And Drug Administration approval being a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is just a clinical-stage biopharmaceutical business that is developing medications centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based management that is pest plant health services and products. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now appropriate to be used on cannabis plants within the Ca cultivation market.
Modern Beverages Corp. (NASDAQ:NBEV)
Modern age Beverages Corp. is really a manufacturer of beverages based on yerba mate, green tea extract, kombucha, and comparable services and products. In current months, modern age has expanded its beverage offerings to add CBD infusions aswell, bringing it in to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in May of 2019, which makes it probably one of the most present cannabis businesses to record from the exchange that is popular. The business was quickly expanding its manufacturing capability and might manage to create just as much as 113,000 kilograms cbd oil for sale of item per by the end of 2019 year.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation operates into the enforcement sector. The company’s business operations support drug assessment through hair examples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is yet another brand new entry on the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) when it announced the production of a unique Palmetto make of leisure cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is really a specialty clinical-stage pharmaceutical business focused in the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted to treat Tourette syndrome and mild cognitive disability.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. had been 1st company that is marijuana-related have a short public providing (IPO) in the usa. The Nanaimo, Vancouver company that is island-based on medical cannabis services and products.
Village Farms Global (NASDAQ:VFF)
Village Farms Overseas is considered the most cannabis that are recent to begin investing on the NASDAQ. The business’s stocks became readily available for trade on February 21, 2019. The business includes a history that is decades-long greenhouse produce production and it has just recently shifted a few of its focus toward cannabis production.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted from the growth of artificial treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline presently includes two drugs being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.